New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
What Is Carcinoma?

What Is Carcinoma?

The most common type of cancer that develops from epithelial cellsByJulia KnoxUpdated on September 25, 2023Medically reviewed byDoru Paul, MDA carcinoma is a type of cancer tha
World medicine November 20,2023
What Is Carcinoma?

What Is Carcinoma?

The most common type of cancer that develops from epithelial cellsByJulia KnoxUpdated on September 25, 2023Medically reviewed byDoru Paul, MDA carcinoma is a type of cancer tha
World medicine November 20,2023
How Lymphoma Is Treated

How Lymphoma Is Treated

Chemotherapy, radiation, and immunotherapy are among the optionsByJames Myhre & Dennis Sifris, MDUpdated on August 29, 2023Medically reviewed byLindsay Cook, PharmDCoping W
World medicine November 20,2023
How Lymphoma Is Treated

How Lymphoma Is Treated

Chemotherapy, radiation, and immunotherapy are among the optionsByJames Myhre & Dennis Sifris, MDUpdated on August 29, 2023Medically reviewed byLindsay Cook, PharmDCoping W
World medicine November 20,2023
How Lung Cancer Is Treated

How Lung Cancer Is Treated

ByLynne Eldridge, MDUpdated on November 17, 2023Medically reviewed byOliver Eng, MDEverything You Need to Know About Lung CancerTreatments forlung cancerhave improv
World medicine November 20,2023
How Lung Cancer Is Treated

How Lung Cancer Is Treated

ByLynne Eldridge, MDUpdated on November 17, 2023Medically reviewed byOliver Eng, MDEverything You Need to Know About Lung CancerTreatments forlung cancerhave improv
World medicine November 20,2023
Glioblastoma Recurrence: Treatment Options and Coping

Glioblastoma Recurrence: Treatment Options and Coping

Treatments, Clinical Trials, and Life ExpectancyByLynne Eldridge, MDUpdated on October 16, 2023Medically reviewed byNicholas R. Metrus, MDGlioblastoma recurrence is, unfortunat
World medicine November 20,2023
Glioblastoma Recurrence: Treatment Options and Coping

Glioblastoma Recurrence: Treatment Options and Coping

Treatments, Clinical Trials, and Life ExpectancyByLynne Eldridge, MDUpdated on October 16, 2023Medically reviewed byNicholas R. Metrus, MDGlioblastoma recurrence is, unfortunat
World medicine November 20,2023
Is Lung Cancer Curable? Treatment Options and Survival Rate

Is Lung Cancer Curable? Treatment Options and Survival Rate

ByLynne Eldridge, MDUpdated on August 03, 2023Medically reviewed byGagandeep Brar, MDLung cancer can be curable in some cases, especially with early diagnosis and treatment. If
World medicine November 20,2023
Is Lung Cancer Curable? Treatment Options and Survival Rate

Is Lung Cancer Curable? Treatment Options and Survival Rate

ByLynne Eldridge, MDUpdated on August 03, 2023Medically reviewed byGagandeep Brar, MDLung cancer can be curable in some cases, especially with early diagnosis and treatment. If
World medicine November 20,2023
Second-Line Axi-Cel Significantly Improves EFS Over Standard of Care in Relapsed/Refractory LBCL

Second-Line Axi-Cel Significantly Improves EFS Over Standard of Care in Relapsed/Refractory LBCL

June 28, 2021Kristi RosaAxicabtagene ciloleucel significantly improved event-free survival by 60% over chemotherapy plus stem cell transplant in the second-line treatment of patients with relapsed or
World medicine November 20,2023
Second-Line Axi-Cel Significantly Improves EFS Over Standard of Care in Relapsed/Refractory LBCL

Second-Line Axi-Cel Significantly Improves EFS Over Standard of Care in Relapsed/Refractory LBCL

June 28, 2021Kristi RosaAxicabtagene ciloleucel significantly improved event-free survival by 60% over chemotherapy plus stem cell transplant in the second-line treatment of patients with relapsed or
World medicine November 20,2023
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com